ITEM METADATA RECORD
Title: PHASE 3 STUDY OF FRONTLINE RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE PLUS VINCRISTINE (R-CHOP) OR BORTEZOMIB (VR-CAP) IN TRANSPLANTATION-UNSUITABLE MANTLE CELL LYMPHOMA (MCL) PATIENTS
Authors: Robak, T
Huang, H
Jin, J
Zhu, J
Liu, T
Samoilova, O
Pylypenko, H
Verhoef, Gregor
Siritanaratkul, N
Osmanov, E
Alexeeva, J
Pereira, J
Mayer, J
Hong, X
Maeda, Y
Pei, L
Rooney, B
van de Velde, H
Cavalli, F
Issue Date: 2014
Publisher: Il Pensiero Scientifico
Host Document: Haematologica vol:99 pages:523-524
Conference: 19th Congress of the European-Hematology-Association location:Milan: ITALY date:JUN 12-15, 2014
ISSN: 0390-6078
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Laboratory of Experimental Hematology (+)

Files in This Item:

There are no files associated with this item.

 


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science